the current study of lymphoblastoid alpha interferon demonstrates the immunomodulatory potential of interferon given to melanoma patients , but it fails to support the hypothesis that augmentation of these parameters of natural immunity by interferon may result in tumor responses .
C0025202
patients
C0021747
interferon